webinar register page

Webinar banner
Virtual Congressional Briefing: Potential of Psychedelics in the Treatment of Psychiatric Diseases: A Long, Strange Trip Toward Future Therapy
Join the American Brain Coalition and American College of Neuropsychopharmacology, in cooperation with Congressman Earl Blumenauer (OR), for a virtual Congressional Briefing examining the role psychedelic drugs are playing in addressing psychiatric illness, including substance use disorders. We will also discuss barriers to research with psychedelic compounds.

Opening Remarks
Representative Earl Blumenauer (D-OR)
Co-Chair, Congressional Neuroscience Caucus

Nora D. Volkow, MD
National Institute on Drug Abuse (NIDA)
National Institutes of Health

Marcus Capone
Former Navy SEAL and founder and chair of VETS Inc.
Operating Partner at Red Cell Partners
Founder of Tåra - Expanding access to Psychedelic Therapy

Rachel Yehuda, PhD
Professor of Psychiatry and Neuroscience of Trauma
Icahn School of Medicine at Mount Sinai
Director of Mental Health
James J. Peters Veterans Affairs Medical Center

Moderator: Mark Rasenick, PhD
Vice Chair, American Brain Coalition
Distinguished Professor of Physiology & Biophysics and Psychiatry
U. Illinois College of Medicine
Research Career Scientist, Jesse Brown VAMC

We hope that you will be able to join us for this informative and timely briefing. This widely-attended event complies with all appropriate regulations.

Sep 21, 2022 02:00 PM in Eastern Time (US and Canada)

Webinar is over, you cannot register now. If you have any questions, please contact Webinar host: .